Fig. 3From: Patient characteristics and outcome of CD20-positive HIV-associated lymphoma: a single-center KwaZulu-Natal, South African hospital 12-year retrospective reviewOverall survival at 2 years by groupAbbreviations: CHOP cyclophosphamide, doxorubicin, vincristine, prednisone, R rituximabBack to article page